Effectiveness of a hybrid technology enabled care model as measured by ICHOM standard set on established and managed type 2 patients already using medications: A RWE retrospective study

Aims

Diabetes is a pressing global health issue, demanding innovative strategies for improved treatment. However, traditional care often falls short of patient goals. To address this, digital health solutions, including smartphone apps and remote monitoring, have emerged as crucial in diabetes management. This study aims to assess a comprehensive intervention, combining remote continuous data monitoring (RCDM) with in-clinic care, for enhancing diabetes-related outcomes. Additionally, it seeks to evaluate the effectiveness of the digital RCDM component by comparing adherent and non-adherent patients.

Methods

Conducted in the United Arab Emirates, a retrospective study involved 89 patients primarily on anti-diabetic medications. They were split into two groups based on adherence to RCDM. Over time, significant improvements were observed across various parameters.

Results

Notably, patients exhibited weight loss (−4.0 ± 5.3, p < 0.001), reduced waist circumference (−4.74 ± 7.8, p < 0.001), lowered HbA1c levels (−1.00 ± 1.3, p < 0.001), decreased systolic BP (−3.1 ± 13.1, p = 0.035), and diminished diastolic BP (−3.4 ± 9.9, p = 0.002) annually. Furthermore, patients adhering to the GluCare model demonstrated substantial HbA1c reductions (−1.53 ± 1.5, p < 0.001), improved lipid profiles, notably decreased total Cholesterol (−16.6 ± 50.3, p = 0.034), and lowered LDL levels (−18.65 ± 42.6, p = 0.006).

Conclusions

The intervention model effectively managed T2D patients through a comprehensive approach, yielding notable improvements in HbA1c levels and other outcomes within a year. The study underscores the limitations of traditional care and reliance simply on pharmacotherapy, and emphasizes the need for a hyper-personalized, and continuous approach for T2D management.